companydata.dkcompanydata.dk

Sqale ApS: Financial statements 2025

CVR: 44359251

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Sqale ApS (CVR 44359251) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 185,439 and a net result of DKK -2,139,319. Equity in the 2025 report amounted to DKK -4,085,607.

Gross Profit
DKK 185,439
Profit/Loss
DKK -2,139,319
Equity
DKK -4,085,607
Total Assets
DKK 277,016

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Sqale ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Sqale ApS enters liquidationOct 31, 2025

On October 31, 2025, Sqale ApS entered liquidation.

Morten Rasmussen joins Sqale ApS as liquidatorOct 28, 2025

As of October 28, 2025, Morten Rasmussen is registered as liquidator of Sqale ApS.

Mads Andersen steps down as adm. dir. of Sqale ApSOct 28, 2025

As of October 28, 2025, Mads Andersen has stepped down as adm. dir. of Sqale ApS.

Sqale ApS enters liquidationOct 28, 2025

On October 28, 2025, Sqale ApS entered liquidation.

Sqale ApS publishes interim reportJun 26, 2025

Sqale ApS has published its interim report for the period October 1, 2023 – December 31, 2024.

About Sqale ApS

Sqale ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Rasmussen. The company is owned by CJS Biotechnology Holdings ApS and B & M Ventures ApS. In 2025, the company reported a gross profit of DKK 185,439 and a net result of DKK -2,139,319. Equity in the 2025 report amounted to DKK -4,085,607.

Source: annual report 2025, Danish Business Authority